
|Articles|April 1, 2006
IDSA issues a hit list
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves risankizumab for pediatric plaque psoriasis and psoriatic arthritis
2
FDA fast tracks BM-3103 gel for epidermolysis bullosa simplex
3
FDA updates in pediatric care: Q2 2026 recap
4
5 FDA decisions to watch for during 2H 2026
5





